Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates

INTRODUCTION: Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by extended-spectrum beta-lactamases and is a good candidate for the treatment of urinary tract infection. However, data are scarce regarding its use in clinical practice. METHODS: We conducted a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Senard, Olivia, Bouchand, Frédérique, Deconinck, Laurene, Matt, Morgan, Fellous, Lesly, Rottman, Martin, Perronne, Christian, Dinh, Aurélien, Davido, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416675/
https://www.ncbi.nlm.nih.gov/pubmed/30891241
http://dx.doi.org/10.1177/2049936118811053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416675/
https://www.ncbi.nlm.nih.gov/pubmed/30891241
http://dx.doi.org/10.1177/2049936118811053

Ejemplares similares